Navigation Links
Huifeng Bio-Pharmaceutical (HFGB) Announces 2007 Full Year Results
Date:3/31/2008

XI'AN, China, March 31 /Xinhua-PRNewswire-FirstCall/ -- Huifeng Bio- Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB), a developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production, is pleased to announce its audited financial results for the year ended December 31, 2007.

Full Year 2007 Highlights:

The following is a summary of our financial results for the full year ended Dec. 31, 2007.

12 Months Ended 12 Months Ended Growth

In US Dollars December 31,2007 December 31,2006 %

Net Revenue $6,571,531 $3,076,779 114%

Gross Profit $1,977,313 $457,518 332%

Gross Profit Margin 30% 15%

Net Income $1,283,683 $131,736 874%

Net Income Margin 20% 4%

Earnings Per Share $0.07 $0.01 600%

Huifeng achieved outstanding growth during 2007, with sales more than doubling and net income increasing by over 800%. "Huifeng achieved a number of significant milestones in 2007. We have increased our product offering and achieved significant sales in both Rutin and Diosmin," states company CEO Jing'An Wang. Furthermore, in late 2007, Huifeng signed the largest supply agreement in company history and completed a $2 million fundraising.

"Huifeng expects to continue achieving significant gains in both sales and net income in 2008 through organic growth of our current products," forecasted Mr. Wang. The company restructured its production lines in the fourth quarter to accommodate the increased production levels of Diosmin necessitated under its current contract with Safic-Alcan of France. Huifeng also hopes to close a strategic acquisition in 2008 under its sta
'/>"/>

SOURCE Huifeng Bio-Pharmaceutical Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
2. Skystar Bio-Pharmaceutical Raises 2007 Revenue Guidance to $15.8 Million
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
5. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
6. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
7. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
8. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2015)... , May 20, 2015  Health eCareers, ... short-staffed healthcare organizations with job seekers looking for ... , a new mobile and online tool dedicated ... healthcare industry. SHIFT enables employers to ... tenens, travel nursing, per diem and other temporary ...
(Date:5/20/2015)... 2015  Haemonetics Corporation (NYSE: HAE ) announced ... will present at The Jefferies 2015 Global Healthcare Conference ... 1 st , 2015 at 8:30am Eastern time.  ... live via webcast at: http://wsw.com/webcast/jeff88/hae ... ) is a global healthcare company dedicated to providing ...
(Date:5/20/2015)... Research and Markets ( http://www.researchandmarkets.com/research/hdsx2f/bone ... "Bone Morphogenetic Proteins Market (Types : rhBMP-2 and ... - Maxillofacial) - Global Industry Analysis, Size, Share, ... report to their offering. The global ... the types of recombinant BMPs, applications, and geography. ...
(Date:5/20/2015)... The Greater Gift Initiative, Inc ... pleased to announce they are donating 10,010 vaccines today ... represent the effort and commitment of clinical trial volunteers ... sites in 2014. , With a mission to ... clinical trial participation, GGI supports International Clinical Trials Day ...
Breaking Biology Technology:Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 2Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 3Global Bone Morphogenetic Proteins Market Industry Analysis 2014 - 2022 2The Greater Gift Initiative Donates over 10,000 Vaccines in Honor of International Clinical Trials Day 2
... TomoTherapy, Inc. , producer of the Hi-Art radiation therapy ... The University Clinic Heidelberg will be the first of ... Hi-Art System, a machine that combines on-board CT imaging with ... healthy tissue. , ,Dr. Jrgen Debus, medical director of the ...
... Saying the nation is at a crucial moment in the development ... supporters of human embryonic stem cell research to bring their "will ... at a symposium of the Center for American Progress , ... a critical moment is because there are politicians who want to ...
... two-part opinion piece on ethanol. Read part one. ... - The environmental arguments surrounding ethanol are plentiful and confusing. , ... These studies were based on computer models. Studies of the actual ... Air Resources Board and others show that in the real ...
Cached Biology Technology:Doyle says practical politics must advance embryonic stem cell research 2Doyle says practical politics must advance embryonic stem cell research 3Last ethanol article you'll ever need to read, Part II 2Last ethanol article you'll ever need to read, Part II 3Last ethanol article you'll ever need to read, Part II 4
(Date:5/11/2015)... May 11, 2015 Curemark LLC, a privately ... of a new Phase III double blind, randomized, placebo-controlled ... formulation, CM-AT, on all children ages 3-8 with Autism. ... Phase III double blinded clinical trial for CM-AT in ... of the digestive enzyme chymotrypsin. This new trial will ...
(Date:5/6/2015)... Israel , May 6, 2015 LifeBEAM, ... most established helmet producer, announced today that they will ... Helmet, the world,s first bio-sensing cycling helmet and the ... released in two new colors in order to give ... the product. In addition, LifeBEAM and Lazer announced their ...
(Date:4/27/2015)... FORT LAUDERDALE, Fla. , Apr. 27, 2015 /PRNewswire/ ... provider of access control and security systems is pleased ... joined the company as a consultant and member of ... Bedore is widely known as a thought leader ... Socrates Distance Learning Technology Group, and has published studies ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
... Management,s (BLM) current practice of removing free-ranging horses from ... maintaining them in long-term holding facilities is both economically ... report by the National Research Council. The report ... manage horses and burros on healthy ecosystems, enhance public ...
... show that the Clean Air Act of 1970 caused a ... an associate professor in the Department of Geosciences, analyzed summer ... area from 1948 to 2009. He discovered that precipitation increased ... of the Clean Air Act of 1970. Diem also ...
... the idea of the possibility of reprogramming the cells ... capacity to differentiate into cells of a completely different ... how it happens. A group from the Spanish ... P. Schneider, from the Telomeres and Telomerase Group led ...
Cached Biology News:New report offers science-based strategies for management of western free-ranging horses and burros 2CNIO researchers identify a new gene that is essential for nuclear reprogramming 2
Goat polyclonal to SART1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: GSSKKHRGEKEAA, corresponding to N terminal amino acids 2-14 of Human SART1. Entrez Gene ID: 909...
...
Rabbit polyclonal to SpUlp2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: SNNERQSLSSGSND, corresponding to amino acids 622-635 of Schizosaccharomyces pombe SpUlp2...
Request Info...
Biology Products: